Why Healthcare Software Companies Get Asked for SOC 2

Enterprise healthcare buyers use SOC 2 as a screening artifact. Without a report you face a long-form security questionnaire instead, which takes longer and produces a weaker impression.

SOC 2 is built on five Trust Services Criteria, and a common misconception is that a report covers all of them. It does not, unless you chose that. Security, expressed through the common criteria, is always in scope. Availability, Processing Integrity, Confidentiality, and Privacy are elective, and each one you add expands the control set, the evidence burden, and the audit fee. Scoping is therefore a commercial decision as much as a technical one, and it should be driven by what your specific buyers ask for rather than by an instinct toward completeness.

The distinction is about time. A Type I report opines on whether controls are suitably designed at a single point in time. A Type II opines on whether they operated effectively across a period, typically three to twelve months. That difference is the entire value proposition to a buyer, because designed controls prove intent while operating controls prove practice. Type I has a legitimate use as an interim milestone when a deal needs something now, but no sophisticated healthcare buyer treats it as equivalent, and presenting it as though it were damages credibility.

The overlap is substantial at the control level and negligible at the obligation level. Access control, encryption, audit logging, change management, incident response, and vendor oversight appear in both frameworks, which means well-built HIPAA controls provide most of a SOC 2 foundation. What SOC 2 does not do is discharge any HIPAA obligation. A clean Type II opinion is not a defense to an OCR investigation, does not create business associate agreements, and does not satisfy breach notification requirements. Healthcare vendors need both because they answer to regulators and to enterprise buyers, and those audiences want different artifacts.

Founders tend to treat the report as a pass or fail artifact. Diligence teams read it as a document. They go to the exceptions first, then the scope boundary, then the complementary user entity controls, then the subservice organization treatment. A report with a clean opinion and a narrow scope that excludes the system the buyer cares about is worth very little, and an experienced reviewer will spot that in minutes. Knowing how the report will be read changes how you scope it.

Most SOC 2 failures are evidence failures rather than control failures. The organization does perform access reviews, but nobody recorded them. Changes are peer reviewed, but the linkage between ticket, approval, and deployment cannot be reconstructed. Logs exist, but no one can demonstrate they were reviewed. Over a twelve month window, an auditor samples across the period, so a control performed diligently but undocumented in month four produces an exception. The engineering objective is therefore automatic evidence generation, not additional process discipline asked of already busy people.

Timing is where SOC 2 most often goes wrong commercially. Companies start the process when a buyer or investor asks, which is exactly when the observation window cannot be compressed to fit. Working backward from the event is the only approach that works: identify when assurance will be demanded, subtract the observation window, subtract remediation time, and that is when readiness work must begin. Companies that sequence correctly present a completed Type II during diligence. Companies that do not spend diligence explaining why they lack one.